Unknown

Dataset Information

0

Pharmacogenomics of IBD Therapies.

ABSTRACT:

SUBMITTER: Dassopoulos T 

PROVIDER: S-EPMC3099313 | biostudies-literature | 2007 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Pharmacogenomics of IBD Therapies.

Dassopoulos Themistocles T  

Gastroenterology & hepatology 20070501 5

Similar Datasets

Unknown Pharmacogenomics of COVID-19 therapies.
| S-EPMC7435176 | biostudies-literature
Unknown Pharmacogenomics of high-density lipoprotein-cholesterol-raising therapies.
| S-EPMC5347146 | biostudies-literature
Unknown Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial Hypercholesterolemia.
| S-EPMC8468752 | biostudies-literature
Unknown Comparative Effectiveness Research: A Roadmap to Sail the Seas of IBD Therapies.
| S-EPMC9697479 | biostudies-literature
Unknown Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD.
| S-EPMC4971798 | biostudies-literature
Unknown The Interplay Between Use of Biological Therapies, Psychological State, and the Microbiome in IBD.
| S-EPMC9345200 | biostudies-literature
Unknown Pharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?
| S-EPMC4486250 | biostudies-literature
Unknown Pharmacogenomics for Prediction of Cardiovascular Toxicity: Landscape of Emerging Data in Breast Cancer Therapies.
| S-EPMC9563074 | biostudies-literature
Unknown Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBD.
| S-EPMC6510223 | biostudies-literature
Unknown A large-scale comparison of clinical outcomes to IBD therapies in White and South Asian ethnicities
| S-EPMC12766419 | biostudies-literature